Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NCT02655016

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site San Francisco, California, United States
View all 116 locations
View Trial Details
Active, Not Recruiting

Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)

NCT07109414

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • HonorHealth Cancer Care Phoenix, Arizona, United States
  • Trials365 Shreveport, Louisiana, United States
  • Optimum Clinical Research Group, LLC Albuquerque, New Mexico, United States
  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

NCT05116189

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations
  • HonorHealth ( Site 0041) Phoenix, Arizona, United States
  • Marin Cancer Care ( Site 0055) Greenbrae, California, United States
  • Pacific Cancer Care ( Site 0028) Monterey, California, United States
  • Eisenhower Medical Center ( Site 0067) Rancho Mirage, California, United States
View all 187 locations
View Trial Details
Active, Not Recruiting

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

NCT03570021

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations
  • Gustave Roussy Villejuif, Val de Marne, France
  • CHU d'Angers Angers, France
  • Hôpital Saint André Bordeaux, France
  • Institut Bergonié Bordeaux, France
View all 21 locations
View Trial Details

Related conditions